Save

Microbiota and epigenetic regulation of inflammatory mediators in type 2 diabetes and obesity

于Beneficial Microbes
著者:
M. Remely Department of Nutritional Sciences, University of Vienna, UZA 2/2D541, Althanstrasse 14, 1090 Vienna, Austria

Search for other papers by M. Remely in
Current site
Google Scholar
PubMed
Close
,
E. Aumueller Department of Nutritional Sciences, University of Vienna, UZA 2/2D541, Althanstrasse 14, 1090 Vienna, Austria

Search for other papers by E. Aumueller in
Current site
Google Scholar
PubMed
Close
,
D. Jahn Department of Nutritional Sciences, University of Vienna, UZA 2/2D541, Althanstrasse 14, 1090 Vienna, Austria

Search for other papers by D. Jahn in
Current site
Google Scholar
PubMed
Close
,
B. Hippe Department of Nutritional Sciences, University of Vienna, UZA 2/2D541, Althanstrasse 14, 1090 Vienna, Austria

Search for other papers by B. Hippe in
Current site
Google Scholar
PubMed
Close
,
H. Brath Diabetes Outpatient Clinic, Health Center South, Wienerbergstrasse 13, 1010 Vienna, Austria

Search for other papers by H. Brath in
Current site
Google Scholar
PubMed
Close
, and
A.G. Haslberger Department of Nutritional Sciences, University of Vienna, UZA 2/2D541, Althanstrasse 14, 1090 Vienna, Austria

Search for other papers by A.G. Haslberger in
Current site
Google Scholar
PubMed
Close
Download Citation 获得许可

Access options

Get access to the full article by using one of the access options below.

Institutional Login

Log in with Open Athens, Shibboleth, or your institutional credentials

Login with Institutional Access

Purchase

Buy instant access (PDF download and unlimited online access):

€36.93

Metabolic syndrome is associated with alterations in the structure of the gut microbiota leading to low-grade inflammatory responses. An increased penetration of the impaired gut membrane by bacterial components is believed to induce this inflammation, possibly involving epigenetic alteration of inflammatory molecules such as Toll-like receptors (TLRs). We evaluated changes of the gut microbiota and epigenetic DNA methylation of TLR2 and TLR4 in three groups of subjects: type 2 diabetics under glucagon-like peptide-1 agonist therapy, obese individuals without established insulin resistance, and a lean control group. Clostridium cluster IV, Clostridium cluster XIVa, lactic acid bacteria, Faecalibacterium prausnitzii and Bacteroidetes abundances were analysed by PCR and 454 high-throughput sequencing. The epigenetic methylation in the regulatory region of TLR4 and TLR2 was analysed using bisulfite conversion and pyrosequencing. We observed a significantly higher ratio of Firmicutes/ Bacteroidetes in type 2 diabetics compared to lean controls and obese. Major differences were shown in lactic acid bacteria, with the highest abundance in type 2 diabetics, followed by obese and lean participants. In comparison, F. prausnitzii was least abundant in type 2 diabetics, and most abundant in lean controls. Methylation analysis of four CpGs in the first exon of TLR4 showed significantly lower methylation in obese individuals, but no significant difference between type 2 diabetics and lean controls. Methylation of seven CpGs in the promoter region of TLR2 was significantly lower in type 2 diabetics compared to obese subjects and lean controls. The methylation levels of both TLRs were significantly correlated with body mass index. Our data suggest that changes in gut microbiota and thus cell wall components are involved in the epigenetic regulation of inflammatory reactions. An improved diet targeted to induce gut microbial balance and in the following even epigenetic changes of pro-inflammatory genes may be effective in the prevention of metabolic syndrome.

内容统计数据

全部期间 过去一年 过去30天
摘要浏览次数 1159 384 19
全文浏览次数 79 64 1
PDF下载次数 55 36 1